rediff.com
e.g. Tata motors, Reliance MF, 500570
Orchid Pharma Ltd. - Research Center
524372 ORCHPHARMA Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Quarterly results in brief
(Rs crore)
Sep' 24 Jun' 24 Mar' 24 Dec' 23 Sep' 23
Sales 222.70 244.41 217.10 220.59 198.76
Operating profit 29.58 33.25 28.92 35.92 23.70
Interest 3.30 3.47 3.45 3.54 3.80
Gross profit 34.25 37.55 38.36 39.81 28.08
EPS (Rs) 5.05 5.74 6.54 6.02 3.99
Quarterly  results in details
Sep' 24 Jun' 24 Mar' 24 Dec' 23 Sep' 23
Other income 7.96 7.77 12.88 7.44 8.18
Stock adjustment -22.56 -2.52 -28.34 -13.68 4.47
Raw material 153.72 152.77 156.47 135.62 117.86
Power and fuel - - - - -
Employee expenses 20.69 21.37 17.57 18.66 17.19
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 41.27 39.53 42.49 44.07 35.53
Provisions made - - - - -
Depreciation 8.63 8.44 8.40 9.27 7.84
Taxation - - -3.23 - -
Net profit / loss 25.63 29.10 33.19 30.55 20.24
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 50.72 50.72 50.72 50.72 50.72
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 13.28 13.60 13.32 16.28 11.92
GPM (%) 14.85 14.89 16.68 17.46 13.57
NPM (%) 11.11 11.54 14.43 13.40 9.78
Close
Add Orchid Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Orchid Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close